手術引流設備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、按應用、最終用途、地區、競爭細分

2022 年全球手術引流設備市場價值為25.2 億美元，預計在預測期內將大幅成長，預計到2028 年年複合成長率將達到6.31%。這些醫療設備被稱為手術引流管，具有促進手術引流的重要功能。從體腔或傷口排出液體和/或氣體。手術引流管通常採用管子的形式，策略性地放置在術後患者手術傷口附近，以有效去除膿液、血液或其他液體等物質，從而防止它們在體內積聚。這些排水管持續發揮作用，有助於在受影響區域保持最佳壓力梯度。

手術引流管有助於清除發炎介質、病原體、外來物和壞死組織，在癒合過程中發揮至關重要的作用。透過這樣做，它們有助於預防恢復期間可能出現的併發症。此外，手術引流管使醫療保健專業人員能夠在整個癒合過程中輕鬆取樣，從而有助於監測潛在問題或併發症。

市場概況
預測期	2024-2028
2022 年市場規模	25.2億美元
2028 年市場規模	36.5億美元
2023-2028 年年複合成長率	6.31%
成長最快的細分市場	醫院
最大的市場	北美洲

主要市場促進因素

外科手術不斷增加

隨著外科手術數量的增加，對外科引流裝置的需求也增加。這些設備對於管理術後積液至關重要，這是許多手術後常見的情況。外科醫生和醫療保健提供者依靠這些設備來確保患者的正常癒合和康復。外科手術涉及廣泛的醫學專業，包括骨科、心血管、一般外科、婦科等。每個外科專業可能需要根據手術的獨特需求客製化特定類型的引流裝置。因此，外科手術的多樣性導致了對各種引流設備的更廣泛的需求，從而推動了市場的成長。微創手術技術的興起增加了手術總數。 MIS 技術通常會產生較小的切口和較少的組織損傷，但它們仍需要引流來控制液體積聚。因此，MIS 的採用促進了對專用微創引流設備的需求增加。由於事故和不可預見的醫療狀況，緊急手術（例如創傷手術或緊急干涉）正在增加。在這些情況下，快速有效的引流解決方案對於預防併發症和支持患者康復至關重要。隨著全球人口老化，需要手術介入的與年齡相關的健康問題的發生率更高。老年患者通常患有合併症，隨著時間的推移可能需要多次手術。在這些病例中，隨著術後護理變得更加重要，對手術引流裝置的需求是顯而易見的。糖尿病和心血管疾病等慢性疾病通常需要外科手術來控制併發症。慢性病患者可能定期接受手術，導致手術引流設備的持續需求。

技術進步

材料科學的進步導致了用於外科引流裝置的更俱生物相容性和耐用性的材料的開發。這些材料可降低組織刺激和過敏反應的風險，同時提高設備的整體性能和使用壽命。增強型材料透過提高排水裝置的接受度和採用率來促進市場的成長。技術創新促進了微創手術技術（MIS）的發展，與傳統的開放性手術相比，微創手術需要更小的切口。 MIS 技術侵入性較小，通常可以縮短住院時間並加快復原速度。這種轉變增加了對專用微創引流裝置的需求，這些裝置可以透過更小的切口有效地控制積液。改進的影像和視覺化技術，例如術中超音波和內視鏡檢查，可以幫助外科醫生評估手術部位和引流的需要。這些技術有助於精確放置引流裝置，降低併發症的風險並改善患者的治療效果。將智慧技術整合到手術引流設備中可以實現即時監控和資料收集。智慧排水管可以測量和傳輸有關液體輸出的資訊，這有助於醫療保健提供者及時做出有關排水管理的決策。該技術改善了患者護理並減少了手動監測的需求，從而推動了此類設備的採用。技術使得引流裝置的設計能夠降低感染風險。抗菌塗層和具有抗菌特性的材料有助於降低設備上細菌定植的風險，從而最大限度地減少術後感染的機會。將遠距醫療和遠端監控解決方案整合到醫療保健系統中已經影響了手術引流設備市場。醫療保健提供者可以遠端監控患者的引流輸出並提供指導，從而減少頻繁的現場追蹤的需要並提高患者的便利性。

有利的監管環境

嚴格的監管標準和要求有助於確保手術引流裝置符合高品質和安全標準。製造商必須遵守嚴格的品質控制流程，以生產可靠、安全的產品。這給醫療保健提供者註入了信心，並鼓勵他們採用這些設備。有利的監管環境加快了製造商進入市場的進程。監管批准（例如歐洲的 CE 標誌或美國的 FDA 許可）對於醫療器材的行銷至關重要。簡化的監管流程可以減少與獲得這些認證相關的時間和成本，使製造商能夠更快地將其產品推向市場。監管機構通常要求手術引流裝置遵守行業標準和指南。製造商必須投資於研發，以確保其設備符合這些標準，從而促進創新並推動改善排水技術的發展。監管機構強制要求上市後監督和不良事件報告。這項要求確保及時識別和解決手術引流裝置的任何安全問題或問題。製造商必須在現場監控其產品並應對安全問題，最終生產出更安全的設備。監管部門的批准意味著手術引流裝置已滿足嚴格的安全性和有效性標準。此認證提高了該設備在醫療保健提供者眼中的可信度和可信度，促進其在臨床環境中的採用和使用。符合國際標準的有利監管環境使製造商更輕鬆地進入全球市場。符合一個國家公認的監管標準的設備通常會被其他地區接受，從而減少進入新市場的障礙。一些監管機構透過贈款和資助計劃支持醫療器材產業的創新和研究。這些措施可以激勵製造商投資研發，以創造先進、更有效的手術引流設備。

主要市場挑戰

監管障礙

獲得外科引流裝置的監管批准可能是一個漫長而複雜的過程。製造商必須提交全面的文件，進行廣泛的測試，並滿足嚴格的品質和安全標準。批准所需的時間和資源可能會延遲產品發布和市場進入，從而阻礙成長。遵守監管要求的成本可能很高。製造商必須投資於研究、測試、品質控制和文件記錄。相關成本可能會讓小公司望而卻步，進而減少市場競爭和創新。不同的國家和地區往往有不同的醫療器材監管架構和標準。對於製造商來說，應對這些變化可能具有挑戰性且成本高昂，特別是當他們尋求在全球範圍內擴展其產品時。這種變化可能導致市場進入的延遲和費用的增加。監管機構要求對市場上的醫療器材進行持續監控。製造商必須報告不良事件並進行上市後監督，這可能會佔用大量資源，並增加持續的營運成本。由於監管審查，一些製造商可能會規避風險，並在創新或為其產品引入新功能方面猶豫不決。這可能會減慢先進手術引流設備的開發和採用，限制市場成長。對於新進入者或規模較小的公司來說，監管要求可能是重大的進入障礙。克服這些障礙所需的時間和成本可能會阻礙競爭並限制創新設備的可用性。

激烈的比賽

激烈的競爭可能會導致價格戰，製造商降低價格以獲得市場佔有率。雖然這有利於醫療保健提供者和患者節省成本，但它可能會對製造商的收入和盈利能力產生負面影響。價格降低也會限制製造商投資研發的能力，可能阻礙先進和創新產品的推出。隨著競爭壓低價格，製造商的利潤率可能會下降。這可能會限制他們再投資業務、擴大產能或從事行銷和促銷活動的能力。反過來，這可能會減緩整體市場的成長。激烈的競爭可能會激勵一些製造商生產模仿現有手術引流裝置的成功設計或功能的山寨產品。雖然這可以為醫療保健提供者帶來更多選擇，但可能會阻礙製造商之間的創新和差異化，從而可能抑制市場成長。在競爭激烈的市場中，製造商可能會急於推出新版本或型號的手術引流裝置。這種快速的周轉可能給必須不斷適應新產品的醫療保健提供者帶來挑戰。它還可能導致市場分散並使供應鏈管理複雜化。激烈的競爭可能導致市場飽和，多家製造商提供類似的產品，幾乎沒有差異化。在這種情況下，新進入者越來越難以立足，可能限制市場擴張。為了保持競爭力，製造商可能會尋找降低生產成本的方法。雖然成本削減措施可以增強競爭力，但它們可能會損害產品品質和安全。這可能會導致監管問題、產品召回以及製造商聲譽受損，最終阻礙市場成長。較小的製造商或新創公司可能會發現在競爭激烈的市場中與成熟的公司競爭具有挑戰性。這可能會阻礙創新並限制新的、潛在顛覆性的手術引流技術或方法的進入。

主要市場趨勢

微創方法

腹腔鏡和內視鏡等微創手術 (MIS) 技術需要專門的手術引流裝置，旨在實現更小的切口和精確的引流。這導致對微創引流解決方案的需求不斷成長，推動市場成長。微創方法可以減少對周圍組織的創傷，從而減少術後併發症。然而，在這些手術中，適當的引流仍然至關重要，以防止積液和感染。專為 MIS 量身訂做的手術引流裝置可提高病患安全性，進而提高其採用率。與傳統的開放性手術相比，微創手術通常會縮短住院時間。高效且有效的引流裝置在管理術後積液、促進患者更快康復和降低醫療成本方面發揮關鍵作用。微創方法優先考慮患者的舒適度和更快的康復。使用不那麼顯眼且可增強移動性的微創引流裝置有助於實現以患者為中心的護理，這是現代醫療保健的成長趨勢。微創手術的興起刺激了手術引流裝置的技術創新。製造商正在開發具有精確控制機制、與 MIS 儀器相容以及人體工學設計等功能的設備，所有這些都增強了它們對醫療保健提供者的吸引力。微創技術正在應用於越來越多的外科專業，包括婦科、泌尿科、骨科和心血管外科。隨著這些專業採用 MIS，對專用排水設備的需求持續成長，使市場多樣化。微創引流裝置透過有效管理積液同時最大程度地減少不適，有助於 MIS 手術的整體成功。這反過來又提高了患者滿意度並加快康復速度，從而加強了微創方法的採用。雖然微創手術的初始設備成本可能較高，但較短的住院時間和降低的併發症發生率可以為醫療保健系統節省成本。這種成本效益進一步鼓勵採用微創方法，包括使用專門的引流裝置。隨著新興市場醫療保健基礎設施的改善，微創技術和相關引流設備的採用正在增加。微創手術的擴張有助於全球手術引流設備市場的整體成長。

智慧互聯排水設備

智慧引流設備可以監控並向醫療保健提供者和遠端監控系統傳輸即時資料，例如液體輸出和壓力。這種能力可以實現主動的患者護理、及早發現問題並及時干涉，最終改善患者的治療結果。連接設備透過持續監控排水參數提供額外的安全保障。如果液體輸出出現異常或突然變化，可以立即向醫療保健提供者發出警報，使他們能夠立即採取行動以防止併發症，例如液體收集或感染。傳統的人工監測排水裝置是勞力密集的，並且可能容易出錯。智慧型設備可自動收集資料，減輕醫護人員的負擔，並最大限度地降低記錄引流資料不準確的風險。智慧引流設備提供的即時資料和見解使醫療保健提供者能夠就引流管理做出更明智的決策。這可以帶來更有效率和個性化的患者護理，確保引流水平保持在所需的範圍內。智慧引流設備可以與遠距醫療平台整合，使醫療保健提供者能夠遠端監控患者的術後進展。這種整合與遠距醫療和遠距醫療服務的日益普及相一致，擴大了醫療保健專業人員的覆蓋範圍並提高了患者的便利性。可以使用資料分析和人工智慧 (AI) 來分析連網排水設備收集的資料。這使得能夠識別患者復健的模式和趨勢，從而可用於預測目的。預測分析可以幫助醫療保健提供者預測併發症並相應地調整引流管理。智慧型設備簡化監測流程，使醫療保健提供者能夠將注意力集中在需要立即介入的患者上，從而促進更有效的資源分配。這可以節省醫療保健環境中的成本並提高資源利用率。連接引流設備透過提供持續監控和更快地回應患者需求，有助於以患者為中心的照護。這增強了術後護理期間患者的整體體驗，並可能導致更高的患者滿意度。監管機構正在認知到智慧互聯醫療設備在提高病患安全方面的潛在好處。監管機構可能會鼓勵採用此類設備，為製造商創造有利的環境並刺激市場成長。提供智慧連網引流設備的製造商透過提供滿足醫療保健提供者和患者不斷變化的需求的先進解決方案來獲得競爭優勢。這可以導致市場佔有率增加和收入成長。

細分市場洞察

應用洞察

根據該申請，預計胸腔外科和心血管外科領域在整個預測期內將大幅市場成長。胸部和心血管手術，例如心臟直視手術和血管手術，非常複雜，通常涉及重要結構的操作。包括冠狀動脈疾病和瓣膜疾病在內的心臟相關疾病的盛行率不斷增加，導致這些手術的數量增加。因此，這些手術領域對專用手術引流裝置的需求也隨之增加。胸部和心血管手術通常需要細緻的術後護理，包括積液的管理。手術引流裝置透過促進從手術部位去除多餘的液體而在這些手術中發揮關鍵作用。它們的有效使用對於預防併發症和確保患者康復至關重要。胸腔和心血管手術的複雜性需要精確且專業的工具和設備。專為這些手術設計的手術引流裝置必須符合嚴格的品質和安全標準。此類專用設備的開發和採用有助於手術引流設備市場的成長。微創方法擴大應用於胸腔外科和心血管手術。這些技術需要針對較小切口和侵入性較小的手術量身定做的引流裝置。隨著這些技術的採用，對專業微創引流解決方案的需求也在增加。胸部和心血管手術後可能會發生術後併發症，例如胸腔積水或血腫形成。手術引流裝置對於有效處理這些併發症至關重要。預防和治療併發症的能力對於病人安全至關重要，從而推動了對引流裝置的需求。胸腔和心血管手術的複雜性導致了手術引流裝置設計的創新。製造商正在開發具有精確控制機制、與手術器械相容以及客製化引流解決方案等功能的設備，以滿足這些手術的獨特需求。介入性心臟病學和微創心臟手術（例如血管成形術和支架置入術）的發展增加了對適合這些微創方法的手術引流裝置的需求。這一趨勢支持了心血管領域的市場成長。

最終使用者見解

基於最終用戶細分市場，醫院細分市場一直是市場的主導力量。醫院是手術引流裝置的主要最終使用者之一。他們的購買決策對市場的成長有重大影響。隨著醫院擴大手術服務範圍並進行更多手術，對手術引流設備的需求不斷增加。醫院優先考慮病患照護和安全。手術引流裝置是術後照護的重要工具，有助於控制積液、預防併發症並促進患者復原。醫院依靠這些設備來確保患者的健康，這推動了它們的持續使用和採用。醫院的目標是盡量減少術後併發症，例如感染和積液。手術引流裝置是實現這一目標的關鍵工具。它們的有效使用可以減少併發症的發生率，從而縮短住院時間並改善患者的治療效果。醫院處於採用新手術技術和技術的最前沿。隨著微創手術和機器人輔助手術變得越來越普遍，醫院尋求為這些手術設計的專門引流設備。這推動了先進手術引流解決方案的創新和開發。手術引流裝置的使用已成為許多外科專業的護理標準。醫院遵循建議使用這些設備的既定指南和最佳實踐，有助於其持續的需求和市場成長。外科醫生和其他醫療保健提供者根據他們的經驗和設備的功效對特定的手術引流設備有偏好。醫院通常會適應這些偏好，導致人們繼續使用和購買首選設備。

區域洞察

北美，特別是手術引流設備市場，在 2022 年佔據市場主導地位，這主要是因為北美，尤其是美國，是全球醫療保健支出率最高的國家之一。對醫療基礎設施、設施和先進醫療技術（包括手術引流設備）的大量投資推動了市場成長。北美是醫療器材創新和研究的中心。該地區的特點是高度重視開發尖端外科技術和設備，其中包括不斷改進外科引流設備。北美擁有大量患者，其中包括大量老年人口。與年齡相關的健康狀況，例如心血管疾病和癌症，通常需要使用外科引流裝置進行外科手術。該地區有大量的外科手術，包括選擇性和非選擇性手術。這些手術通常需要使用手術引流裝置來處理術後併發症，這增加了需求。

目錄

第 1 章：產品概述

• 市場定義
• 市場範圍
  • 涵蓋的市場
  • 研究年份
  • 主要市場區隔

第 2 章：研究方法

• 研究目的
• 基線方法
• 主要產業夥伴
• 主要協會和二手資料來源
• 預測方法
• 數據三角測量與驗證
• 假設和限制

第 3 章：執行摘要

• 市場概況
• 主要市場細分概述
• 主要市場參與者概述
• 重點地區/國家概況
• 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球手術引流裝置市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品（主動、被動）
  • 按應用（胸腔及心血管手術、神經外科手術、腹部手術、骨科、其他）
  • 依最終用途（醫院、門診手術中心、診所）
  • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
  • 按公司分類 (2022)
• 市場地圖
  • 按產品分類
  • 按應用
  • 按最終用途
  • 按地區

第 6 章：北美手術引流設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品（主動、被動）
  • 按應用（胸腔及心血管手術、神經外科手術、腹部手術、骨科、其他）
  • 依最終用途（醫院、門診手術中心、診所）
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲手術引流設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品（主動、被動）
  • 按應用（胸腔及心血管手術、神經外科手術、腹部手術、骨科、其他）
  • 依最終用途（醫院、門診手術中心、診所）
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太地區手術引流設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品（主動、被動）
  • 按應用（胸腔及心血管手術、神經外科手術、腹部手術、骨科、其他）
  • 依最終用途（醫院、門診手術中心、診所）
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲手術引流設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品（主動、被動）
  • 按應用（胸腔及心血管手術、神經外科手術、腹部手術、骨科、其他）
  • 依最終用途（醫院、門診手術中心、診所）
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲手術引流裝置市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品（主動、被動）
  • 按應用（胸腔及心血管手術、神經外科手術、腹部手術、骨科、其他）
  • 依最終用途（醫院、門診手術中心、診所）
  • 按國家/地區
• MEA：國家分析
  • 南非手術引流裝置
  • 沙烏地阿拉伯手術引流裝置
  • 阿拉伯聯合大公國手術引流裝置

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球手術引流裝置市場：SWOT 分析

第 14 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• 商業概覽
• 產品供應
• 最近的發展
• 財務（據報導）
• 主要人員
• SWOT分析
  • Acelity LP Inc.
  • Teleflex Incorporated.
  • Cardinal Health.
  • Medtronic PLC.
  • Cook Medical.
  • Stryker Corporation.
  • CR Bard.
  • Ethicon, Inc.
  • B. Braun Melsungen.
  • Medela A G.

第 16 章：策略建議

The Global Surgical Drainage Devices Market, valued at USD 2.52 Billion in 2022, is poised for substantial growth in the forecast period, projecting a robust CAGR of 6.31% through 2028. These medical devices, known as surgical drains, serve the vital function of facilitating the drainage of fluid and/or gas from bodily cavities or wounds. Surgical drains typically take the form of tubes strategically placed near surgical wounds in post-operative patients to effectively remove substances such as pus, blood, or other fluids, thereby preventing their accumulation within the body. These drains function continuously, helping to maintain an optimal pressure gradient in the affected areas.

Surgical drains play a crucial role in the healing process by aiding in the removal of inflammatory mediators, pathogens, foreign objects, and necrotic tissue. By doing so, they contribute to the prevention of complications that may arise during recovery. Moreover, surgical drains enable healthcare professionals to easily sample fluid throughout the healing journey, facilitating the monitoring of potential issues or complications.

In essence, the Global Surgical Drainage Devices Market is on a trajectory of significant growth due to the indispensable role played by surgical drains in post-operative care. Their ability to efficiently manage fluid drainage, prevent complications, and support the healing process underscores their importance in the field of healthcare.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 2.52 Billion
Market Size 2028	USD 3.65 Billion
CAGR 2023-2028	6.31%
Fastest Growing Segment	Hospitals
Largest Market	North America

Key Market Drivers

Rising Surgical Procedures

As the number of surgical procedures grows, so does the need for surgical drainage devices. These devices are essential for managing post-operative fluid accumulation, which is a common occurrence after many surgeries. Surgeons and healthcare providers rely on these devices to ensure the proper healing and recovery of patients. Surgical procedures span a wide range of medical specialties, including orthopedics, cardiovascular, general surgery, gynecology, and more. Each surgical specialty may require specific types of drainage devices tailored to the unique needs of the procedure. The diversity of surgical procedures thus leads to a broader demand for a variety of drainage devices, driving market growth. The rise of minimally invasive surgical techniques has increased the overall number of surgeries performed. MIS techniques often result in smaller incisions and less tissue damage, but they can still require drainage to manage fluid buildup. Consequently, the adoption of MIS has contributed to the increased demand for specialized minimally invasive drainage devices. Emergency surgeries, such as trauma surgeries or urgent interventions, are on the rise due to accidents and unforeseen medical conditions. In these cases, quick and effective drainage solutions are essential to prevent complications and support patient recovery. As the global population ages, there is a higher incidence of age-related health issues that require surgical intervention. Elderly patients often have comorbidities and may require multiple surgeries over time. The need for surgical drainage devices in these cases is pronounced, as post-operative care becomes more critical. Chronic diseases, such as diabetes and cardiovascular diseases, often require surgical procedures to manage complications. Patients with chronic conditions may undergo surgeries regularly, contributing to the sustained demand for surgical drainage devices.

Technological Advancements

Advancements in materials science have led to the development of more biocompatible and durable materials for surgical drainage devices. These materials reduce the risk of tissue irritation and allergic reactions while improving the overall performance and longevity of the devices. Enhanced materials contribute to the market's growth by increasing the acceptance and adoption of drainage devices. Technological innovations have facilitated the growth of minimally invasive surgical techniques (MIS), which require smaller incisions compared to traditional open surgeries. MIS techniques are less invasive and typically result in shorter hospital stays and quicker recoveries. This shift has increased the demand for specialized minimally invasive drainage devices that can effectively manage fluid accumulation through smaller incisions. Improved imaging and visualization technologies, such as intraoperative ultrasound and endoscopy, aid surgeons in assessing the surgical site and the need for drainage. These technologies help in precise placement of drainage devices, reducing the risk of complications and enhancing patient outcomes. The integration of smart technology into surgical drainage devices allows for real-time monitoring and data collection. Smart drains can measure and transmit information about fluid output, which aids healthcare providers in making timely decisions regarding drainage management. This technology improves patient care and reduces the need for manual monitoring, driving the adoption of such devices. Technology has enabled the design of drainage devices with features that reduce the risk of infections. Antimicrobial coatings and materials with antimicrobial properties can help mitigate the risk of bacterial colonization on the device, thereby minimizing the chances of post-operative infections. The integration of telemedicine and remote monitoring solutions into healthcare systems has impacted the surgical drainage devices market. Healthcare providers can remotely monitor patients' drainage output and provide guidance, reducing the need for frequent in-person follow-ups and improving patient convenience.

Favorable Regulatory Environment

Rigorous regulatory standards and requirements help ensure that surgical drainage devices meet high-quality and safety standards. Manufacturers are compelled to adhere to strict quality control processes, leading to the production of reliable and safe products. This instills confidence among healthcare providers and encourages them to adopt these devices. A favorable regulatory environment expedites the process of market entry for manufacturers. Regulatory approvals, such as CE Marking in Europe or FDA clearance in the United States, are essential for marketing medical devices. A streamlined regulatory process can reduce the time and cost associated with obtaining these certifications, allowing manufacturers to bring their products to market more quickly. Regulatory agencies often require surgical drainage devices to adhere to industry standards and guidelines. Manufacturers must invest in research and development to ensure their devices comply with these standards, fostering innovation and driving the development of improved drainage technologies. Regulatory bodies mandate post-market surveillance and adverse event reporting. This requirement ensures that any safety concerns or issues with surgical drainage devices are promptly identified and addressed. Manufacturers must monitor their products in the field and respond to safety concerns, ultimately leading to safer devices. Regulatory approval signifies that a surgical drainage device has met rigorous safety and efficacy standards. This certification enhances the credibility and trustworthiness of the device in the eyes of healthcare providers, facilitating its adoption and use in clinical settings. Favorable regulatory environments that align with international standards enable manufacturers to access global markets more easily. A device that complies with recognized regulatory standards in one country is often accepted in other regions, reducing barriers to entry into new markets. Some regulatory agencies support innovation and research in the medical device industry through grants and funding programs. These initiatives can incentivize manufacturers to invest in research and development to create advanced and more effective surgical drainage devices.

Key Market Challenges

Regulatory Hurdles

Obtaining regulatory approvals for surgical drainage devices can be a lengthy and intricate process. Manufacturers must submit comprehensive documentation, conduct extensive testing, and meet stringent quality and safety standards. The time and resources required for approvals can delay product launches and market entry, impeding growth. Complying with regulatory requirements can be expensive. Manufacturers must invest in research, testing, quality control, and documentation. The associated costs may be prohibitive for smaller companies, reducing competition and innovation in the market. Different countries and regions often have distinct regulatory frameworks and standards for medical devices. Navigating these variations can be challenging and costly for manufacturers, especially when they seek to expand their products globally. This variability can lead to delays in market entry and added expenses. Regulatory agencies require continuous monitoring of medical devices in the market. Manufacturers must report adverse events and conduct post-market surveillance, which can be resource-intensive and add ongoing costs to the operation. Due to the regulatory scrutiny, some manufacturers may become risk-averse and hesitant to innovate or introduce new features to their products. This can slow down the development and adoption of advanced surgical drainage devices, limiting market growth. For new entrants or smaller companies, the regulatory requirements can be significant barriers to entry. The time and costs associated with meeting these hurdles can discourage competition and limit the availability of innovative devices.

Intense Competition

Fierce competition can lead to price wars, with manufacturers reducing prices to gain market share. While this benefits healthcare providers and patients in terms of cost savings, it can negatively impact the revenue and profitability of manufacturers. Reduced prices can also limit the ability of manufacturers to invest in research and development, potentially hindering the introduction of advanced and innovative products. As competition drives down prices, manufacturers may experience thinner profit margins. This can limit their ability to reinvest in their businesses, expand production capacity, or engage in marketing and promotional activities. In turn, this may slow down the overall market growth. Intense competition may incentivize some manufacturers to create copycat products that mimic successful designs or features of existing surgical drainage devices. While this can lead to more choices for healthcare providers, it may discourage innovation and differentiation among manufacturers, potentially stifling market growth. In a highly competitive market, manufacturers may rush to introduce new versions or models of surgical drainage devices. This rapid turnover can create challenges for healthcare providers who must constantly adapt to new product offerings. It may also lead to fragmentation in the market and complicate supply chain management. Intense competition can lead to market saturation, where multiple manufacturers offer similar products with little differentiation. In such a scenario, it becomes increasingly difficult for new entrants to gain a foothold, potentially limiting market expansion. To remain competitive, manufacturers may look for ways to cut production costs. While cost-cutting measures can enhance competitiveness, they may compromise product quality and safety. This can lead to regulatory issues, product recalls, and damage to a manufacturer's reputation, ultimately hindering market growth. Smaller manufacturers or startups may find it challenging to compete with well-established companies in a highly competitive market. This can discourage innovation and limit the entry of new, potentially disruptive technologies or approaches to surgical drainage.

Key Market Trends

Minimally Invasive Approaches

Minimally invasive surgery (MIS) techniques, such as laparoscopy and endoscopy, require specialized surgical drainage devices designed for smaller incisions and precise drainage. This has led to a growing demand for minimally invasive drainage solutions, driving market growth. Minimally invasive approaches are associated with reduced trauma to surrounding tissues, resulting in fewer post-operative complications. However, proper drainage is still crucial in these procedures to prevent fluid accumulation and infections. Surgical drainage devices tailored for MIS enhance patient safety, leading to their increased adoption. Minimally invasive surgeries often result in shorter hospital stays compared to traditional open surgeries. Efficient and effective drainage devices play a critical role in managing post-operative fluid accumulation, facilitating quicker patient recovery, and reducing healthcare costs. Minimally invasive approaches prioritize patient comfort and faster recuperation. The use of minimally invasive drainage devices that are less obtrusive and offer enhanced mobility contributes to patient-centered care, which is a growing trend in modern healthcare. The rise of minimally invasive surgery has spurred technological innovations in surgical drainage devices. Manufacturers are developing devices with features like precise control mechanisms, compatibility with MIS instruments, and ergonomic designs, all of which enhance their appeal to healthcare providers. Minimally invasive techniques are being applied to an increasing number of surgical specialties, including gynecology, urology, orthopedics, and cardiovascular surgery. As these specialties adopt MIS, the demand for specialized drainage devices continues to grow, diversifying the market. Minimally invasive drainage devices contribute to the overall success of MIS procedures by effectively managing fluid accumulation while minimizing discomfort. This, in turn, promotes patient satisfaction and faster recovery, reinforcing the adoption of minimally invasive approaches. While the initial equipment costs for minimally invasive surgery can be higher, the shorter hospital stays and reduced complication rates can result in cost savings for healthcare systems. This cost-efficiency further encourages the adoption of minimally invasive approaches, including the use of specialized drainage devices. As healthcare infrastructure improves in emerging markets, the adoption of minimally invasive techniques and associated drainage devices is on the rise. This expansion of minimally invasive surgeries contributes to the overall growth of the global surgical drainage devices market.

Smart and Connected Drainage Devices

Smart drainage devices can monitor and transmit real-time data, such as fluid output and pressure, to healthcare providers and remote monitoring systems. This capability allows for proactive patient care, early detection of issues, and timely interventions, ultimately improving patient outcomes. Connected devices provide an added layer of safety by continuously monitoring drainage parameters. In the event of anomalies or sudden changes in fluid output, healthcare providers can be alerted promptly, enabling them to take immediate action to prevent complications, such as fluid collection or infection. Traditional manual monitoring of drainage devices is labor-intensive and may be prone to errors. Smart devices automate data collection, reducing the burden on healthcare staff and minimizing the risk of inaccuracies in recording drainage data. The real-time data and insights provided by smart drainage devices enable healthcare providers to make more informed decisions regarding drainage management. This can lead to more efficient and personalized patient care, ensuring that drainage levels are kept within the desired range. Smart drainage devices can be integrated with telemedicine platforms, allowing healthcare providers to remotely monitor patients' post-operative progress. This integration aligns with the growing adoption of telehealth and telemedicine services, expanding the reach of healthcare professionals and improving patient convenience. The data collected by connected drainage devices can be analyzed using data analytics and artificial intelligence (AI). This enables the identification of patterns and trends in patient recovery, which can be used for predictive purposes. Predictive analytics can help healthcare providers anticipate complications and adjust drainage management accordingly. Smart devices facilitate more efficient resource allocation by streamlining the monitoring process and enabling healthcare providers to focus their attention on patients who require immediate intervention. This can lead to cost savings and improved resource utilization in healthcare settings. Connected drainage devices contribute to patient-centered care by offering continuous monitoring and quicker response times to patient needs. This enhances the overall patient experience during post-operative care and may lead to higher patient satisfaction rates. Regulatory agencies are recognizing the potential benefits of smart and connected medical devices in improving patient safety. Regulatory bodies may encourage the adoption of such devices, creating a favorable environment for manufacturers and stimulating market growth. Manufacturers offering smart and connected drainage devices gain a competitive advantage by providing advanced solutions that meet the evolving needs of healthcare providers and patients. This can lead to increased market share and revenue growth.

Segmental Insights

Application Insights

Based on the Application, the thoracic and cardiovascular surgeries segment is anticipated to witness substantial market growth throughout the forecast period. Thoracic and cardiovascular surgeries, such as open-heart procedures and vascular surgeries, are intricate and often involve the manipulation of vital structures. The increasing prevalence of heart-related conditions, including coronary artery disease and valvular disorders, has led to a higher volume of these surgeries. As a result, the demand for specialized surgical drainage devices in these surgical fields has also increased. Thoracic and cardiovascular surgeries typically require meticulous post-operative care, including the management of fluid accumulation. Surgical drainage devices play a critical role in these procedures by facilitating the removal of excess fluids from the surgical site. Their efficient use is essential in preventing complications and ensuring patient recovery. The complex nature of thoracic and cardiovascular surgeries demands precision and specialized tools and devices. Surgical drainage devices designed specifically for these procedures must meet stringent quality and safety standards. The development and adoption of such specialized devices contribute to the growth of the surgical drainage devices market. Minimally invasive approaches are increasingly utilized in thoracic and cardiovascular surgeries. These techniques require drainage devices tailored to smaller incisions and less invasive procedures. The demand for specialized minimally invasive drainage solutions has grown in parallel with the adoption of these techniques. Post-operative complications, such as pleural effusion or hematoma formation, can occur after thoracic and cardiovascular surgeries. Surgical drainage devices are essential for managing these complications effectively. The ability to prevent and treat complications is crucial for patient safety, driving the demand for drainage devices. The complexity of thoracic and cardiovascular surgeries has led to innovations in surgical drainage device design. Manufacturers are developing devices with features such as precise control mechanisms, compatibility with surgical instruments, and tailored drainage solutions to meet the unique demands of these procedures. The growth of interventional cardiology and minimally invasive cardiac procedures, such as angioplasty and stent placement, has increased the demand for surgical drainage devices that are suitable for these less invasive approaches. This trend supports market growth in the cardiovascular segment.

End User Insights

Based on the End User segment, the Hospitals segment has been the dominant force in the market. Hospitals are among the primary end-users of surgical drainage devices. Their purchasing decisions significantly impact the market's growth. As hospitals expand their surgical services and perform a higher volume of procedures, the demand for surgical drainage devices increases. Hospitals prioritize patient care and safety. Surgical drainage devices are essential tools in post-operative care, helping manage fluid accumulation, prevent complications, and promote patient recovery. Hospitals rely on these devices to ensure the well-being of their patients, which drives their consistent use and adoption. Hospitals aim to minimize post-operative complications, such as infections and fluid accumulation. Surgical drainage devices are key instruments in achieving this goal. Their effective use can reduce the incidence of complications, resulting in shorter hospital stays and better patient outcomes. Hospitals are at the forefront of adopting new surgical techniques and technologies. As minimally invasive and robotic-assisted surgeries become more common, hospitals seek specialized drainage devices designed for these procedures. This drives innovation and the development of advanced surgical drainage solutions. The use of surgical drainage devices has become a standard of care in many surgical specialties. Hospitals follow established guidelines and best practices that recommend the use of these devices, contributing to their consistent demand and market growth. Surgeons and other healthcare providers have preferences for specific surgical drainage devices based on their experience and the devices' efficacy. Hospitals often accommodate these preferences, leading to the continued use and purchase of preferred devices.

Regional Insights

North America, specifically the Surgical Drainage Devices Market, dominated the market in 2022, primarily due to North America, particularly the United States, has one of the highest healthcare expenditure rates globally. The substantial investment in healthcare infrastructure, facilities, and advanced medical technologies, including surgical drainage devices, drives market growth. North America is a hub for medical device innovation and research. The region is characterized by a strong focus on developing cutting-edge surgical technologies and devices, which includes the continuous improvement of surgical drainage devices. North America has a sizable patient pool, including a significant elderly population. Age-related health conditions, such as cardiovascular diseases and cancer, often necessitate surgical procedures that require the use of surgical drainage devices. The region witnesses a high volume of surgical procedures, both elective and non-elective. These surgeries often require the use of surgical drainage devices to manage post-operative complications, thereby increasing demand.

Key Market Players

• Acelity L.P Inc.

• Teleflex Incorporated.

• Cardinal Health.

• Medtronic PLC.

• Cook Medical.

• Stryker Corporation.

• C.R. Bard.

• Ethicon, Inc.

• B. Braun Melsungen.

• Medela A G

Report Scope:

In this report, the Global Surgical Drainage Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Surgical Drainage Devices Market, By Product:

• Active
• Passive

Surgical Drainage Devices Market, By Application:

• Thoracic & Cardiovascular Surgeries
• Neurosurgical Procedures
• Abdominal Surgery
• Orthopedics
• Others

Surgical Drainage Devices Market, By End Use:

• Hospitals
• Ambulatory surgical centers
• Clinics

Surgical Drainage Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Surgical Drainage Devices Market.

Available Customizations:

• Global Surgical Drainage Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Surgical Drainage Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Active, Passive)
    • 5.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 5.2.1.2 By Passive (Penrose Drain, Others)
  • 5.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 5.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Product
  • 5.3.2 By Application
  • 5.3.3 By End-Use
  • 5.3.4 By Region

6. North America Surgical Drainage Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Active, Passive)
    • 6.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 6.2.1.2 By Passive (Penrose Drain, Others)
  • 6.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 6.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Surgical Drainage Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Surgical Drainage Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Surgical Drainage Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Surgical Drainage Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Active, Passive)
    • 7.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 7.2.1.2 By Passive (Penrose Drain, Others)
  • 7.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 7.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Surgical Drainage Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. Germany Surgical Drainage Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Surgical Drainage Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Surgical Drainage Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Surgical Drainage Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia-Pacific Surgical Drainage Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Active, Passive)
    • 8.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 8.2.1.2 By Passive (Penrose Drain, Others)
  • 8.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 8.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Surgical Drainage Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Surgical Drainage Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Surgical Drainage Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Surgical Drainage Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Surgical Drainage Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. South America Surgical Drainage Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Active, Passive)
    • 9.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 9.2.1.2 By Passive (Penrose Drain, Others)
  • 9.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 9.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Surgical Drainage Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. Argentina Surgical Drainage Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. Colombia Surgical Drainage Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. Middle East and Africa Surgical Drainage Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Active, Passive)
    • 10.2.1.1 By Active Product (Jackson Pratt Drain, Hemovac Drain, Blake Drain, Negative Pressure Wound Therapy, Redivac Drain, EVD & Lumbar Drain, Chest Tube, Others)
    • 10.2.1.2 By Passive (Penrose Drain, Others)
  • 10.2.2. By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others)
  • 10.2.3. By End-use (Hospitals, Ambulatory surgical centers, Clinics)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Surgical Drainage Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Saudi Arabia Surgical Drainage Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. UAE Surgical Drainage Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Surgical Drainage Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Acelity L.P Inc.
  • 15.6.2 Teleflex Incorporated.
  • 15.6.3 Cardinal Health.
  • 15.6.4 Medtronic PLC.
  • 15.6.5 Cook Medical.
  • 15.6.6 Stryker Corporation.
  • 15.6.7 C.R. Bard.
  • 15.6.8 Ethicon, Inc.
  • 15.6.9 B. Braun Melsungen.
  • 15.6.10 Medela A G.

16. Strategic Recommendations